|Bid||2.9500 x 2200|
|Ask||4.0700 x 800|
|Day's Range||2.9900 - 3.1800|
|52 Week Range||1.3500 - 5.4200|
|Beta (3Y Monthly)||2.93|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
is expected to report earnings of 2 cents a share on sales of $14.4 million after the market closes on on May. 15, based on a FactSet survey of two analysts. The company's American depository receipts have risen 49.5% since the company last reported earnings on Apr. 1. Quarterly estimates have fallen less than 1 cent a share in the past month.
Unfortunately, investing is risky - companies can and do go bankrupt. On the other hand, if you find a high quality business to buy (at the right price) you can more than double your money! Take, for example EDAP TMS S.A. (NA...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 1) Abbott Laboratories (NYSE: ABT ) AEterna Zentaris Inc. ...
The big shareholder groups in EDAP TMS S.A. (NASDAQ:EDAP) have power over the company. Institutions often own shares in more established companies, while it's not unusual to see insiders own Read More...
While small-cap stocks, such as EDAP TMS SA (NASDAQ:EDAP) with its market cap of US$78m, are popular for their explosive growth, investors should also be aware of their balance sheet Read More...